43 results
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
15 Aug 24
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
8:40am
and equipment, net
Operating lease right-of-use assets, net
Deferred tax assets, net
Intangible assets, net
Other assets, non-current
Total non-current … operations
Other income (expenses):
Late fees for taxes other than income tax
Late fees for social security insurance
Government grants
Financial expenses
424B3
v9pan5hvp0glsgea l96
8 May 24
Prospectus supplement
8:32am
6-K
EX-99.3
w4qd0
7 May 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
nnde 2n0mqasqcnz
19 Apr 24
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
8:03am
POS AM
wgm2uxpn7 cwdz
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
6-K
EX-99.1
rqur 2mnm89z
22 Jan 24
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
5:10pm
424B3
16d9ad3u3hq5xma1
25 Sep 23
Prospectus supplement
6:07am
6-K
EX-99.1
0lz3p8oc
16 Aug 23
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
8:00am
424B3
82dibh0szi
15 Aug 23
Prospectus supplement
8:00am
POS AM
888iw6i6
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
7q8d5y47
26 Jul 23
Annual report (foreign)
4:02pm
20-F
EX-2.1
hsuvnvohu7xt0ojt
26 Jul 23
Annual report (foreign)
4:02pm
424B3
vt379b0eowhc239wycs
5 Jun 23
Prospectus supplement
4:03pm